Latest ADAR1 Capital Management, LLC Stock Portfolio
ADAR1 Capital Management, LLC Performance:
2025 Q3: 40.47%YTD: 36.6%2024: -1.37%
Performance for 2025 Q3 is 40.47%, and YTD is 36.6%, and 2024 is -1.37%.
About ADAR1 Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ADAR1 Capital Management, LLC reported an equity portfolio of $1.1 Billions as of 30 Sep, 2025.
The top stock holdings of ADAR1 Capital Management, LLC are , KROS, PTGX. The fund has invested 10.8% of it's portfolio in ABIVAX SA and 8% of portfolio in KEROS THERAPEUTICS INC.
The fund managers got completely rid off SAGE THERAPEUTICS INC (SAGE), VERVE THERAPEUTICS INC (VERV) and HELIX ACQUISITION CORP II stocks. They significantly reduced their stock positions in OVID THERAPEUTICS INC (OVID), ORUKA THERAPEUTICS INC and CENTESSA PHARMACEUTICALS PLC (CNTA). ADAR1 Capital Management, LLC opened new stock positions in INVIVYD INC (ADGI), METSERA INC and EQUILLIUM INC (EQ). The fund showed a lot of confidence in some stocks as they added substantially to REPLIMUNE GROUP INC (REPL), ASCENDIS PHARMA A/S and SUMMIT THERAPEUTICS INC (SMMT).
The top stock holdings of ADAR1 Capital Management, LLC are , KROS, PTGX. The fund has invested 10.8% of it's portfolio in ABIVAX SA and 8% of portfolio in KEROS THERAPEUTICS INC.
The fund managers got completely rid off SAGE THERAPEUTICS INC (SAGE), VERVE THERAPEUTICS INC (VERV) and HELIX ACQUISITION CORP II stocks. They significantly reduced their stock positions in OVID THERAPEUTICS INC (OVID), ORUKA THERAPEUTICS INC and CENTESSA PHARMACEUTICALS PLC (CNTA). ADAR1 Capital Management, LLC opened new stock positions in INVIVYD INC (ADGI), METSERA INC and EQUILLIUM INC (EQ). The fund showed a lot of confidence in some stocks as they added substantially to REPLIMUNE GROUP INC (REPL), ASCENDIS PHARMA A/S and SUMMIT THERAPEUTICS INC (SMMT).
ADAR1 Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ADAR1 Capital Management, LLC made a return of 40.47% in the last quarter. In trailing 12 months, it's portfolio return was 27.19%.
New Buys
| Ticker | $ Bought |
|---|---|
| invivyd inc | 8,108,090 |
| metsera inc | 7,981,420 |
| equillium inc | 7,950,780 |
| uniqure nv | 7,781,660 |
| bridgebio oncology therapeut | 5,804,220 |
| atai life sciences nv | 4,831,050 |
| united therapeutics corp del | 4,695,150 |
| krystal biotech inc | 3,269,860 |
New stocks bought by ADAR1 Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| replimune group inc | 9,312 |
| ascendis pharma a/s | 2,492 |
| lexeo therapeutics inc | 955 |
| summit therapeutics inc | 758 |
| sanofi sa | 642 |
| fulcrum therapeutics inc | 540 |
| janux therapeutics inc | 465 |
| quince therapeutics inc | 442 |
Additions to existing portfolio by ADAR1 Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| bridgebio pharma inc | -99.00 |
| bridgebio pharma inc | -99.00 |
| ovid therapeutics inc | -88.91 |
| oruka therapeutics inc | -85.4 |
| centessa pharmaceuticals plc | -81.92 |
| akero therapeutics inc | -81.47 |
| mineralys therapeutics inc | -74.1 |
| biomx inc | -74.08 |
ADAR1 Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| alector inc | -2,412,940 |
| ardelyx inc | -3,587,310 |
| sage therapeutics inc | -6,580,980 |
| third harmonic bio inc | -3,382,200 |
| aa mission acquisition corp | -49,702 |
| verve therapeutics inc | -5,267,070 |
| helix acquisition corp ii | -4,700,570 |
| vir biotechnology inc | -1,260,000 |
ADAR1 Capital Management, LLC got rid off the above stocks
Sector Distribution
ADAR1 Capital Management, LLC has about 65.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65.8 |
| Others | 32.9 |
Market Cap. Distribution
ADAR1 Capital Management, LLC has about 6.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 33.2 |
| MID-CAP | 29.1 |
| SMALL-CAP | 20.4 |
| MICRO-CAP | 7.6 |
| LARGE-CAP | 6.3 |
| NANO-CAP | 3.2 |
Stocks belong to which Index?
About 43.4% of the stocks held by ADAR1 Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 56.5 |
| RUSSELL 2000 | 41.5 |
| S&P 500 | 1.9 |
ADAR1 Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ADAR1 Capital Management, LLC
ADAR1 Capital Management, LLC has 197 stocks in it's portfolio. About 48.5% of the portfolio is in top 10 stocks. MLTX proved to be the most loss making stock for the portfolio. was the most profitable stock for ADAR1 Capital Management, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABOS | acumen pharmaceuticals inc | 0.14 | 891,183 | 1,523,920 | reduced | -2.73 | ||
| ABUS | arbutus biopharma corp | 1.24 | 2,903,230 | 13,180,600 | added | 2.74 | ||
| ACHV | achieve life sciences inc | 0.01 | 47,800 | 150,570 | added | 10.72 | ||
| ACLX | arcellx inc | 0.24 | 31,484 | 2,584,840 | added | 125 | ||
| ACRS | aclaris therapeutics inc | 0.07 | 373,682 | 709,996 | new | |||
| ADGI | invivyd inc | 0.76 | 7,370,990 | 8,108,090 | new | |||
| AGIO | agios pharmaceuticals inc | 0.14 | 37,000 | 1,485,180 | added | 3.06 | ||
| AGLE | spyre therapeutics inc | 0.05 | 34,051 | 570,695 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 0.03 | 6,143 | 291,670 | reduced | -81.47 | ||
| ALDX | aldeyra therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALEC | alector inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 0.16 | 56,200 | 1,686,000 | added | 24.89 | ||
| AMLX | amylyx pharmaceuticals inc | 1.11 | 866,202 | 11,771,700 | reduced | -28.12 | ||
| APLS | apellis pharmaceuticals inc | 0.04 | 20,000 | 452,600 | added | 17.65 | ||
| ARDX | ardelyx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 0.07 | 82,591 | 703,675 | reduced | -35.86 | ||
| ARWR | arrowhead pharmaceuticals in | 0.16 | 49,800 | 1,717,600 | reduced | -9.78 | ||
| ASMB | assembly biosciences inc | 0.05 | 18,947 | 485,043 | new | |||
| ATAI | atai life sciences nv | 0.45 | 913,242 | 4,831,050 | new | |||
| ATXS | astria therapeutics inc | 0.13 | 193,934 | 1,411,840 | reduced | -22.32 | ||